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Background: Pre-genomic and post-genomic studies demonstrate that chlamydiae actively recombine in vitro and
in vivo, although the molecular and cellular biology of this process is not well understood. In this study, we
determined the genome sequence of twelve Chlamydia trachomatis recombinants that were generated in vitro
under antibiotic selection. These strains were used to explore the process of recombination in Chlamydia spp.,
including analysis of candidate recombination hotspots, and to correlate known C. trachomatis in vitro phenotypes
with parental phenotypes and genotypes.
Results: Each of the 190 examined recombination events was the product of homologous recombination, and no
candidate targeting motifs were identified at recombination sites. There was a single deletion event in one
recombinant progeny that resulted in the removal of 17.1 kilobases between two rRNA operons. There was no
evidence for preference for any specific region of the chromosome for recombination, and analyses of a total of
over 200 individual recombination events do not provide any support for recombination hotspots in vitro. Two
measurable phenotypes were analyzed in these studies. First, the efficiency of attachment to host cells in the
absence of centrifugation was examined, and this property segregated to regions of the chromosome that carry
the polymorphic membrane protein (Pmp) genes. Second, the formation of secondary inclusions within cells varied
among recombinant progeny, but this did not cleanly segregate to specific regions of the chromosome.
Conclusions: These experiments examined the process of recombination in C. trachomatis and identified tools that
can be used to associate phenotype with genotype in recombinant progeny. There were no data supporting the
hypothesis that particular nucleotide sequences are preferentially used for recombination in vitro. Selected
phenotypes can be segregated by analysis of recombination, and this technology may be useful in preliminary
analysis of the relationship of genetic variation to phenotypic variation in the chlamydiae.
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Chlamydia trachomatis is a Gram-negative obligate
intracellular bacterium that is a leading cause of prevent-
able blindness and sexually transmitted diseases world-
wide [1]. Much of the biology of infection and disease
remains unclear in this system, owing largely to the lack* Correspondence: rockeyd@orst.edu
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reproduction in any medium, provided the orof a routine genetic system for these organisms. While
many aspects of these challenges have recently been
overcome [2,3], the use of genetic transformation in this
system is just beginning to be exploited. One aspect of
chlamydial biology that is poorly understood involves
the mechanism of lateral gene transfer among chlamy-
dial strains both in the laboratory and, most likely, in pa-
tients. Coinfection of host cells in vitro with chlamydial
isolates encoding different drug resistance markers lead
to generation of dual resistant recombinant progeny
[4,5]. These results lend support to pre- and post-genomic
analyses demonstrating that chlamydiae recombine in
infected hosts [6-12], likely following infection of a patientLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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recognizable bacterial gene transfer systems, thus the
mechanisms underlying chlamydial recombination re-
main unknown.
C. trachomatis and many other chlamydiae are differ-
entiated into distinct serovars based on antibody specifi-
city to the major outer membrane protein (MOMP or
OmpA), encoded by ompA. Serovars and subserovars of
C. trachomatis fall into three groups those associated
with trachoma (serovars A, B, and C), those associated
with non-invasive sexually transmitted infections of the
urogenital tract (serovars D through K), and those asso-
ciated with invasive lymphogranuloma (LGV; serovars
L1 to L3) [14]. This historical classification system has
recently been modified to a genotypic characterization
of strains, both by sequencing of ompA and the inclusion
of a variety of other markers in the analysis [15-17].
Nevertheless, many of the biological differences among
chlamydiae still can be grouped by the serovar-based
classification scheme. Clinically relevant differences
among the chlamydiae include host tropism, variation in
disease outcome, and in vitro biology. With some excep-
tions (reviewed in [18]), such as tryptophan utilization
[19,20] and fusogenicity of inclusions [21], the relation-
ship between genotype and phenotype is not clear
in vitro and certainly not with regards to how the phe-
notypes observed in cell culture relate to the disease po-
tential of a particular strain. Two such phenotypes that
are different among C. trachomatis strains include the
historical difference among serovars regarding attach-
ment and invasion in the presence or absence of cen-
trifugation during the infectious process [22], and
secondary inclusion formation by different chlamydial
strains [23]. Deciphering the genetic basis of these and
other phenotypes is complicated by the relatively primi-
tive molecular genetic techniques that have been avail-
able for studying chlamydial biology, although this
situation is changing.
In the present study, genetically mosaic recombinant
strains from parents with differing cell culture pheno-
types were generated in vitro, cloned by limiting dilu-
tion, and subjected to complete genome sequence
analysis. These strains, the parentals used in the crosses,
and selected clinical isolates were used to investigate the
process of chlamydial genetic exchange, and to develop
and test a system for a primary examination of attach-
ment and invasion as well as secondary inclusion forma-
tion phenotypes in C. trachomatis.
Results
Generation of recombinant strains
A collection of recombinant strains was generated using
parent strains within serovars J, F, and L2 (Table 1, Figure 1).
These included IncA-positive strains J/6276 and L2-434,and the IncA negative strain F(s)/70. In some cases,
crosses involved two parents (i.e. crosses 1–6, 11,12);
while in other cases three-way crosses were attempted (i.e.
Table 1, crosses 7–10). Each of these crosses yielded
expected inclusion fusion patterns, leading to cells
infected with both IncA-positive strains forming fused in-
clusions, while cells infected with either IncA-positive
strain and the F(s)/70 IncA-negative strain having multiple
inclusions per cell. Mixtures of all three of these strains
led to cells having mixed inclusions containing the two
IncA-positive strains, and a set of isolated inclusions
containing the IncA-negative F(s)/70 strain (Figure 2).
While progeny with each possible combination of two
antibiotic resistance markers were routinely identified in
the three-way crosses, no triply resistant strain was reco-
vered in any experiment. Additionally, no single progeny
strain had sequence at any informative position from each
of the three parents in a three-way cross. Recombinant
progeny were generated in crosses of both IncA-positive
and IncA-negative parents, with no apparent difference in
the rate of recovery of recombinants relative to the IncA
status of the parent (not shown).
Genome sequence analysis of recombinant strains
The genomes of the twelve recombinant strains were se-
quenced using Illumina paired-end technology (Figure 3).
In all recombinant strains, the sequences surrounding
the individual resistance markers were derived from the
appropriate parent, supporting the conclusion that these
were recombinant strains and not spontaneous mutants
that emerged during the selection process. There was
evidence of a single random mutation in one recombin-
ant, strain RC-L2(s)/3. This mutation was a G (L2-434
sequence) to A [RC-L2(s)/3] substitution at position
293,505 (genome accession CP002676), resulting in an
alanine to valine amino acid change in the protein pro-
duct of CT258. This same mutation was identified in the
RC-J(s)/122 genome, a progeny of a cross in which RC-
L2(s)/3 was a parent. There was no other evidence of
random base change in any other sequenced recombin-
ant genome.
With one exception, the exchange of DNA in each re-
combination event yielded products consistent with clas-
sical gene conversion or homologous recombination.
The exception involves a recombination/deletion event
involving the ribosomal operons which occurred in the
cross between parental strains RC-L2(s)/3 and RC-J/
6276tet yielding recombinant strain RC-J(s)/122 (Table 1,
cross 12). This cross led to a deletion of one of the three
ribosomal operons found in most of the in vitro-gener-
ated Tetr C. trachomatis strains (Figure 1, [5]), returning
the progeny strain to the number of ribosomal operons
found in wild-type C. trachomatis and other closely
related species (Figure 4). This event also led to the
Table 1 Phenotypes of parents and progeny in recombinant crosses
MIC (μg/ml) Phenotype
Cross Progeny Parental strains OmpA Rif Ofl Tet Plasmid Inclusion fusion Attachment 2° inclusion formation
1 RC-J/6276tet J 8 0.5 8 - + - 2
L2-434tet-13 L2 0.008 16 8 + + + 1
J/6276rif J 8 0.5 0.032 - + - 1
2 RC-F(s)/342 F 32 0.5 8 - - - N/A
RC-J/6276tet-rif J 8 0.5 8 - + - 1
F(s)/70rif F 32 0.5 0.032 - - - N/A
3 RC-L2(s)/46 L2 32 16 0.032 + - + N/A
L2-434ofl L2 0.008 16 0.032 + + + 1
F(s)70rif F 32 0.5 0.032 - - - N/A
4 RC-F/69 F 32 4 0.032 + + + 1
L2-434ofl L2 0.008 16 0.032 + + + 1
F(s)70rif F 32 0.5 0.032 - - - N/A
5 RC-L2(s)/3 L2 32 4 0.032 - - + N/A
L2-434ofl L2 0.008 16 0.032 + + + 1
F(s)70rif F 32 0.5 0.032 - - - N/A
6 RC-L2/55 L2 32 4 0.032 - + + N/A
L2-434ofl L2 0.008 16 0.032 + + + 1
F(s)/70rif F 32 0.5 0.032 - - - N/A
7 RC-J/953 J 8 16 0.032 + + + 4
L2-434ofl L2 0.008 16 0.032 + + + 1
RC-F(s)/343tet-rif F 32 0.5 8 - - - N/A
J/6276rifR J 8 0.5 0.032 - + - 1
8 RC-J/943 J 8 16 0.032 + + + 1
L2-434/ofl L2 0.008 16 0.032 + + + 1
RC-F(s)/343tet-rif F 32 0.5 8 - - - N/A
J/6276rif J 8 0.05 0.032 - + - 1
9 RC-J/966 J 8 16 0.032 + + + 1
L2-434/ofl L2 0.008 16 0.032 + + + 1
RC-F(s)/343tet-rif F 32 0.5 8 - - - N/A
J/6276rif J 8 0.5 0.032 - + - 1
10 RC-L2/971 J 8 16 0.032 + + + 4
L2-434/ofl L2 0.008 16 0.032 + + + 1
RC-F(s)/343tet-rif F 32 0.5 8 - - - N/A
J/6276rif J 8 0.5 0.032 - + - 1
11 RC-F(s)/852 F 32 4 8 + - - N/A
RC-F/69 F 32 4 0.032 + + + 1
RC-F(s)/343tet-rif F 32 0.5 8 - - - N/A
12 RC-J(s)/122 J 32 4 8 - - + N/A
RC-L2(s)/3 L2 32 4 0.032 - - + N/A
RC-J/6276tet-rif J 8 0.5 8 - + - 1
Plasmid phenotype tests for presence and genotype of plasmid.
Progeny strains used in subsequent recombinant crosses are shown in bold face.























Figure 1 The genealogy of recombinant strains generated and explored in this study. The figure shows the parental strains used to
generate recombinant strains. In each case, the parents in a cross are connected by a horizontal line, and the progeny are at the end of the
arrow. In some cases, the progeny of one cross was used as a parent in a subsequent cross. Primary parental strain names includes drug
resistance, and all recombinant strains (indicated by prefix RC- ) are both rifampicin and ofloxacin resistant. The colors used indicate the OmpA
phenotype of each strain, as determined by fluorescence microscopy and genome sequence analysis. Strains containing the plasmid are shown
in bold face and underlined. Crosses involving three parents are not shown because no triply drug resistant strains could be recovered.
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in a progeny strain that contains only the C. suis homologs
of CT740 through CT749. The results demonstrate that
these C. suis sequences can complement any required
function of the deleted C. trachomatis genes for growth
in vitro.
Nucleotide sequence analysis of the recombinant
genomes showed that some of these isolates lacked the
chlamydial plasmid (Table 1, Figure 1). We originally hy-
pothesized that loss of the plasmid was associated in some
way with the recombination process. To explore this pos-
sibility, PCR analyses were performed on all recom-
binants, as well as the parents used in this study. Both the
J/6276rif and the F(s)/70rif parents were negative for the
plasmid, whereas the L2-434ofl parent was plasmid-
positive (Table 1, Figure 1). Because plasmid was absent in
both the J/6276rif and the F(s)/70rif parents used in the
crosses, plasmid loss in the resulting progeny was likely a
function of stress associated with antibiotic-based selec-tion of strains prior to generating recombinants as opposed
to a stress induced by the recombination process.
The sequenced recombinant genomes allowed a com-
parative survey of recombination events in progeny
strains. The largest fragment that was laterally trans-
ferred during recombination was 412,907 base pairs,
found in RC-J(s)/122, while the smallest documented
double crossover event was a 7 base pair fragment in the
RC-L2(s)/3 strain.
A total of 190 independent crossover regions were
detected in the 12 recombinant strains. The distribution
of these recombination sites was examined by mapping
each crossover position from each of the 12 sequenced
genomes to a single arbitrarily chosen F(s)/70 parental
genome (Figure 5). There was generally a higher concen-
tration of crossovers surrounding the rpoB locus (associ-
ated with Rif resistance), and there were large regions of
the chromosome that lacked evidence of recombination,
such as the region surrounding CT001.
Figure 3 Genome maps of recombinant strains, derived from complete nucleotide sequence analysis. The colors used in recombinant
maps indicate the parental genotype, as is indicated at the top of the figure. The Tet(C) island is originally from C. suis R19. The approximate
location of the genetic markers used in the construction of the recombinant genomes is shown above the RC-J/6276tet genome map. Below
each strain name is the antibiotic resistance markers that the recombinant strain carries. The bracket and number below each genome map
indicate the largest size of contiguous integrated DNA. The small brackets above each genome map indicate crossover regions that were
confirmed by PCR amplification and Sanger sequencing.
Figure 2 Fluorescent microscopy showing host cells infected with three C. trachomatis strains. Strains were labeled with primary
antibodies against OmpA. Cells are infected with L2-434 (green), J/6276 (red), and the inclusion fusion negative strain F(s)/70 (blue). Scale
bar, 5 μm.
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Figure 4 Schematic diagram of the CT740 to CT749 regions in selected recombinant sequences. The colors used indicate the genotype of
a given region. The ribosomal operons are shown in yellow, and crossover sites are shown in black. The deletion of the C. trachomatis homologous
region of CT740 to CT749 in the RC-J(s)/122 sequence is indicated by the delta symbol.
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recombination at specific positions within trpB or gyrA
in several recombinant progeny originally generated by
Demars and Weinfurter [4]. We used two approaches to
examine selected sets of candidate hotspots identified by
these authors. First, we examined our original 12 recom-
binant genomes for recombination events at common
sites. While analysis of these fully sequenced recombin-
ant strains identified four examples of recombination
events that occurred within the same genetic region in
independent progeny strains (Table 2, Figures 3 and 5),
and none were found in more than 2 recombinant pro-
geny. Second, we conducted PCR-based sequence analysis






Figure 5 The genomic location of crossover regions in each of
the twelve sequenced recombinant progeny strains. The
sequenced strain D/UW3Cx gene designations were used as the
reference, with the location of gene CT001 indicated at the top
of representative genome. The black tick marks indicates the
location of a crossover region. The location of the plasticity zone
is shown in gray.crosses, using parental combinations (D/UW3Cx X L1/
440/LN; D/UW3Cx X L3/404/LN) that were nearly identi-
cal to those analyzed by Srinivasan and colleagues [24]. In-
dependence of these crosses was assured because each of
the 14 examined progeny was the product of a fully inde-
pendent cross of parental strains. In no examined case
was there evidence for recombination at either of the loci
identified by these authors, in any of the 14 progeny
strains generated from these crosses (Table 3).
Chi sites have previously been described as sites for
homologous recombination in bacteria [25,26], and it is
possible that a canonical chi site, or other sequence pat-
tern, might be found at or near chlamydial recom-
bination sites. The program MEME [27] was used to
determine if any identified crossover sites were linked to
a common sequence motif. These analyses support the
hypothesis that recombination in vitro does not require
specific target sequences and occurs at random sites
across the genome.Genotypes associated with attachment efficiency
Attachment efficiency in the presence or absence of
centrifugation is a differentiating phenotype among C.
trachomatis strains [22]. Strains of serovar L2 have a
high rate of attachment in static culture, while the non-
LGV serovars have a reduced ability to infect in the
absence of centrifugation (Figure 6, [22]). We used a PCR-
based analysis of attached EBs to examine the efficiency
of attachment in our recombinant strains, relative to the
parents of the crosses. Parental strains performed as pre-
dicted in these assays, with our serovar L2 strain having
little dependence on centrifugation for attachment, while
centrifugation enhanced attachment by both the serovar F
and Serovar J parental strains (Figure 6). However, the
different recombinant progeny strains showed variability
in attachment efficiency relative to ompA genotype,
with individual progeny strains reflecting the attach-
ment efficiency of either the Serovar L2 or serovar F/J
parental strain.
Table 2 A comparison of shared crossover sites in different progeny strains
Recombinant RC-L2(s)/3 RC-F(s)/342
Region of crossover CT778 (priA) CT778 (priA)
Coordinates 916870 : 917156 954495 : 955597
Comments F(s)70 - L2-434 hybrid CT778 F(s)70 - J/6276 hybrid CT778
Recombinant RC-L2(s)/3 RC-J/966
Region of crossover CT331 (dxs) and CT332 (pykF) CT332 (pykF)
Coordinates 377279 : 377995 370626 : 37785
Comments F(s)70 CT331, L2-434 CT332 J/6276 - L2-434 hybrid CT332
Recombinant RC-L2/971 RC-J/966
Region of crossover CT569 (gspG) and CT570 (gspF) CT569 (gspG) and CT570 (gspF)
Coordinates 634854 : 636140 635246 : 636532
Comments J/6276 CT569, L2-434 CT570 J/6276 CT569, L2-434 CT570
Recombinant RC-L2/971 RC-L2/55
Region of crossover CT585 (trpS) and CT586 (uvrB) CT586 (uvrB)
Coordinates 655362 : 656561 656865 : 657292
Comments L2-434 CT585, J/6276 CT586 F(s)70 - L2-434 hybrid CT586
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determine if regions in the chlamydial genome could be
associated with the observed attachment efficiency
phenotype. Briefly, the sequenced recombinant genomes
are aligned (12 recombinant strains and 3 parental
strains), and every informative site (any position in the
alignment where a different genotype is present) is ana-
lyzed using the Fisher’s exact test to determine if that
genotype is associated with observed phenotype. FiveTable 3 Analysis of independent recombinant strains for
recombination hot-spots















Individual recombinant progeny from independent crosses were subjected to
PCR-based DNA sequencing and assessed for recombination at positions
identified as hotspots by Srinivasan and colleagues [24]. For each sequenced
product, the identified genotype at that region is indicated (D or L1/L3). There
were no examples of recombination in any of these sequenced PCR products.genomic regions were identified that had the highest
possible inverse Log p-value based on sample size and each
observation group size (Additional file 1: Figure S1).
These include regions containing ORFs CT001 – CT089,
CT139 – CT146, CT203 – CT215, CT740 – CT746, and
CT783 – CT875. The predicted proteins encoded within
these regions of the 3 parents and 12 recombinants were
then compared using the MUSCLE sequence alignment
software, and a total of 124 proteins had at least one non-
synonymous amino acid change that was associated with
the attachment phenotype (Additional file 2: Table S1). The
chlamydial membrane proteins PmpE (14 amino acid
changes), PmpF (110 AA changes), PmpG (28 AA changes),
and PmpH (57 AA changes) were among the proteins with
the highest number of non-synonymous amino acid
changes. Other relevant genes that were associated with
high attachment efficiency were ORFs CT089, and CT860 -
862, ORFs encoding proteins involved in the Type III se-
cretion process [28,29]. Differences in the sequences of
proteins demonstrated by others to function in primary
attachment (OmpA, [30], OmcB [31]) or proposed to be
associated with very early events following contact
(HSP70, [32]) were not associated with differential attach-
ment efficiency, as measured by our assay (Figure 6).
Variation in secondary inclusion formation between
recombinant strains
Formation of secondary inclusions in infected cells is an-
other trait that varies among strains and serovars. For
example, strains of serovars G and F commonly form
secondary inclusions at a higher rate than strains of
serovar J and L2 [23]. We explored the secondary inclu-
sion phenotype of IncA-positive recombinant strains;
Figure 6 Attachment efficiency and subsequent genomic analysis of parental and progeny recombinant strains. Panel A: Measurement
of the attachment efficiency for parental and recombinant strains. The specific strains analyzed are represented on the x-axis (center of figure),
and the percent attachment efficiency is represented on the y-axis. Dark gray bars represent parental strains, and light gray bars represent
recombinant strains. Panel B: The genotype of each strain for the 9 pmp genes and 3 other genes previously discussed as being associated with
attachment are shown below each strain in graph. The colored boxes indicate the parental genotype of each gene, as indicated at the bottom of
the figure. The pmp genes that are associated with attachment efficiency are indicated in bold. Boxes containing two colors indicate that a
crossover event occurred within the gene in this strain.
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negative, because our readout of secondary inclusions is
dependent on antibodies to IncA. Of the eight IncA-
positive recombinant strains tested, recombinants RC-J/
953 and RC-L2/971 showed extensive secondary inclu-
sion production (Table 1, Figure 7). These results are sur-
prising because both parental strains (J/6276 and L2-434)
used to create RC-J/953 and RC-L2/971 are low secondary
inclusion formers [23]. Recombinant progeny with high
secondary inclusion phenotypes where both parents ex-
hibit low secondary inclusion formation suggest a possible
interaction between at least two chlamydial proteins, or at
least two independent genetic markers, in the manifest-
ation of the secondary inclusion phenotype.
Quantitative analysis of possible loci associated with
the secondary inclusion phenotype was inconclusive.
This was a function of both the low number of
recombinants available for analysis, and the fact the ap-
parently multiple alleles are involved.Discussion
Genetic manipulation of chlamydiae has been a historical
barrier to research in this system, but some of these
barriers have recently been removed. One such area of
progress is the use and understanding of chlamydial
recombination. There is considerable evidence for in vitro
and in vivo recombination by chlamydiae, and the methods
for generating chlamydial recombinants are becoming
routine [4,5,24]. However, there remains a general lack
of understanding regarding the cellular and molecular
mechanisms associated with the process. The present study
was initiated to address these challenges. We hypothesized
that an investigation of both the process of genetic recom-
bination in chlamydiae and the correlation of specific chla-
mydial genotypes with phenotypes can be addressed using
a combination of contemporary genome sequencing tech-
nologies with our ability to create genetic recombinants
among chlamydiae. This approach has also been used by
Nguyen and colleagues [33] as part of a forward genetic
Figure 7 Fluorescent microscopic analysis of the secondary
inclusion formation phenotype of recombinant strain RC-J/953.
McCoy cells were infected at an MOI of ~0.5, and images were
taken 48 h post-infection. All cells were labeled with anti-IncA
(green), and anti-OmpA (red), and DNA is labeled with DAPI (blue). A
representative secondary inclusion is indicated by the white arrow in
the bottom panel. The strain being analyzed is shown at the right of
each image. Scale bar, 10 μm.
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ments can be integrated with the recently developed chla-
mydial transformation system [3] to develop and validate
correlations between gene structure and protein function.
Evidence for recombination in chlamydiae was first
provided by nucleotide sequencing of genes or genomes
taken from a variety of chlamydial strains. There are
data in the literature suggesting that recombination
hotspots might be present within or around ompA
[7,11,12], and also at other locations in the genome [34].
Our genome sequencing has added some support for
this premise, as the D(s)/2923 genome discussed by
Jeffrey et al. [10] has a hybrid D/E OmpA sequence, and
apparent recombination sites within this strain are at or
very near sites seen in other, independently isolated,
clinical strains [9,11]. Other investigators have proposed
and debated the concept of chlamydial recombination
hotspots using analysis of chlamydial genome sequences
from laboratory-generated or clinical strains [8,24,35]. In
the present study, we used two strategies to investigatethe possible clustering of recombination events in vitro.
First, we analyzed apparent crossover sites by genome
sequencing of 12 recombinant genomes, which led to
the identification of a total of 190 primary recombin-
ation sites. The largest integrated fragment identified in
these experiments was over 400,000 base pairs, which
constitutes approximately 40% of the chlamydial gen-
ome. The long recombined region observed in these
progeny strains are consistent with the original obser-
vations of Demars and Weinfurter [4], who discuss very
large exchanges in their recombinants. Sequence data
from clinical isolates do not provide evidence for such
large exchanged fragments, but there is clear evidence
of recombined regions of greater than 50,000 base
pairs [6,10,35]. Chlamydial genomes are remarkably
homogenous and syntenous, and we hypothesize that
many recombination events that may have occurred,
both in clinical strains and in laboratory-generated pro-
geny, have been missed because of the low level of over-
all genomic variability.
Our data provided no evidence for increased frequency
of particular recombination at specific sites surrounding
markers used for selection (Figure 5). Certain areas of
the genome were apparently devoid of recombination
events, but these areas also were not physically linked to
any of the selectable markers used for these studies. Our
data provide no basis for these chromosomal sections
being refractory to recombination. A total of four gen-
omic locations were identified as possible recombination
targets in more than one independent progeny clone.
None of these four positions is identified as a recombi-
nation hotspot in other studies [9]. No candidate hotspot
regions within or immediately around ompA were identi-
fied in any of our in vitro recombinants, and none of the
positions are directly flanking the markers used for
selection.
A second approach to investigate chlamydial recom-
bination hotspots was in response to work of Srinivasan
et al. [24] who examined sequence data generated by
Demars and Weinfurter [4], and identified candidate re-
combination hotspots at several loci. We attempted to
replicate these results by making completely indepen-
dent recombinant clones using strains very similar to
those used by these investigators, and examining pre-
dicted loci for evidence of recombination. These clones
were determined to be fully independent, because each
was derived from a completely independent primary
mixture of parental strains. We found no evidence of the
use of recombination sites identified by Srinivasan and
colleagues in any of the clones. Our inability to identify
any hotspots surrounding previously identified recom-
bination sites leads us to propose that most previously
identified recombination hotspots were identified as
such because: 1) there was significant in vivo selection
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antigenic variation), or 2) the position being analyzed is
identified because there simply was more sequence het-
erogeneity in that region of the chromosome, or 3) the
in vitro progeny identified as containing recombination
hotspots were siblings in a single recombination event
prior to being cloned out of a population.
Each recombination event identified appeared to be a
product of homologous recombination or gene conver-
sion between highly related sequences. There was a sin-
gle deletion event in one progeny strain, in which two
virtually identical rRNA sequences were precisely de-
leted to yield a single rRNA operon, with 17 kB of inter-
vening sequences (10 genes, CT740 through CT749)
removed in the process [RC-J(s)/122, Figure 4]. This was
the only example of a deletion in any progeny strain,
and there were no cases of a duplication event. These re-
sults are consistent with the general sequence similarity
and synteny found in the naturally mosaic C. trachomatis
genomes, with occasional phenotype-associated deletions
in specific regions of the chromosome [36,37].
The three-way crosses were designed to examine the
possibility that multiple parents could be involved in
generation of a single recombinant progeny. We saw no
evidence of a three-way cross in any of our selection ex-
periments or in any genome sequence analysis, even
though multiple independent two-way crosses were re-
covered from those experiments. If the probability of a
three-way event is a function of the probability of two
independent recombination events, it is likely that not
enough individual recombinants were screened to iden-
tify an extremely rare progeny clone. There is, however,
one issue that is addressed by the absence of any evi-
dence for contribution of three parents in a cross. In
many of the recombinants identified by our group and
in studies by Demars and colleagues [4,38], multiple
fragments from each parental genome are found in a re-
combinant progeny, often in regions of the chromosome
that were not selected for with the tested antibiotics
(Figures 3 and 5). It is possible that these differently
recombined fragments involve sequential and independ-
ent recombination events occurring during the mixed
infections used in this procedure. If involvement of mul-
tiple chlamydiae was a common occurrence in the gen-
eration of a cross, we hypothesized that some progeny
from the three-way crosses should carry fragments of
each parent. As no single progeny strain was identified
with fragments of each of the parents in the three-way
cross, our results do not support this hypothesis. There-
fore our current model is that the generation of recom-
binant progeny is the result of a single exchange event
between two parents, and that these exchanges can in-
volve very large fragments of the chromosomal DNA.
This latter result is consistent with analyses by otherlaboratories [4,9,33,35,38]. Subsequent recombination
events will then lead to differential integration of frag-
ments of the exchanged DNA, leading to the mosaicism
seen in many of the recombinants.
The attachment efficiency in the absence of centrifuga-
tion measured for the different recombinants revealed
groups having either a high attachment efficiency, as
exhibited by LGV strains, or a low attachment efficiency,
as exhibited by non-LGV urogenital strains (Figure 6).
Genome wide association analysis of this phenotype re-
vealed a number of loci that were quantitatively associ-
ated with the attachment efficiency phenotype seen in
cell culture. While the list of candidate alleles that might
be associated with this phenotype includes a wide varie-
ty of genes (i.e. type III secretion –associated ORFs
[28,29]), we focus this discussion on proteins known or
hypothesized to be on the surface of the chlamydial
elementary body. One collection of proteins that is
highly associated with attachment efficiency were six of
the Pmp proteins (PmpDEFGHI), a group of chlamydia-
specific autotransporters, some of which are known to
be surface exposed and are logical mediators of attach-
ment to cells [39]. A bioinformatic analysis of Pmp se-
quence and structure demonstrates that four of these
encoded Pmps (PmpEFGH) vary consistently in relation-
ship to the described phenotype, and these changes include
alterations of the net negative charge of the Pmp protein
(Additional file 2: Tables S1-S2 and Additional file 3:
Table S2). It is, however, preliminary to assess any pro-
perty of a single protein or small set of proteins with the
attachment efficiency distinction among strains. The re-
cently developed genetic transformation system will be
a critical technology in directly assessing such relation-
ships in this species [3].
The second phenotype investigated in our study was
the formation of secondary inclusions within infected
cells. This property of C. trachomatis strains varies not
only between C. trachomatis serovars, but also between
strains within serovars [23]. An intriguing result was the
identification of high secondary inclusion formers in
crosses between parents that exhibited very low second-
ary inclusion formation phenotypes (Table 1, Figure 7).
While interpretations of this result are preliminary, it
appears that the phenotype is associated with two or
more regions of the genome, and that a specific combi-
nation of genotypes at these positions is required for
the high secondary inclusion formation phenotype to
be manifested.
Continued examination of novel recombinants, includ-
ing backcrosses to integrate more parental genome into
recombinant strains will add clarity to the phenotypes
we have discussed. We also continue to use the re-
combinants as tools to understand the basic processes
associated with genetic exchange in the chlamydiae.
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The described experiments characterize in detail the
products of genetic exchange by C. trachomatis in vitro.
Sequences representing over 1/3 of the chlamydial
chromosome can be incorporated during these crosses.
Selected phenotypes can be segregated in these crosses.
This approach can be combined with the novel DNA
transformation technologies being developed in these
bacteria, leading to novel approaches for determining
the relationship between genetic makeup and chlamydial
phenotype, both in vitro and in vivo.
Methods
Chlamydial strains and selection for resistance
Antibiotic resistant C. trachomatis strains J/6276rif, RC-J
/6276tet-rif, F(s)/70rif, F(s)/70tet-rif L2-434ofl,DUW/3Cx ofl,
L1/440/LNrif or L3/404/LNrif were generated as previously
described [5]. Briefly, strains were grown in McCoy cells
at a multiplicity of infection (MOI) of 1 in media
containing sub-inhibitory concentrations, equivalent to
half the minimum inhibitory concentration (MIC) of the
appropriate drug. Serial passages of these strains were cul-
tured in the media containing desired antibiotics until re-
sistant mutants emerged or until passage was completely
negative. Some strains required several attempts until
resistant mutants were isolated. Isolates were then cloned
by a twofold limiting dilution method. The resulting
cloned elementary bodies (EBs) were grown to high titers
and were partially purified by centrifugation of lysates of
infected cells through a 30% MD-Gastroview® pad
(Mallinckrodt Inc. St Louis).
Generation of recombinant clones for complete genome
sequence analysis
Recombinants isolated for genome analysis were gener-
ated from two sets of crosses (Table 1). The first of these
involved two parental strains; L2-434ofl and F(s)/70rif
and the second was a three-way cross with the parental
strains F(s)/70tet-rif, J/6276rif and L2-434ofl. Recombination
experiments were conducted as previously described [5].
Briefly, crosses were performed in McCoy cells seeded in
sets of individual shell vials. The monolayers were then
infected with different combinations of drug-resistant
strains each at an MOI = 2, ensuring infections of cells
with both strains. Cultures were incubated for 48 h post-
infection in the absence of antibiotics and were then de-
tached and lysed using a -80C/37C freeze-thaw cycle [5].
Potential recombinants were selected by inoculating 50 μl
of the freeze-thaw lysates from each shell vial onto a new
shell vial monolayer and overlaying with a medium
containing antibiotics at 1/4 the MIC for each resistant
parental strain. In the case of the three-way cross [F(s), J,
L2], three different combinations of drug were applied to
the infected monolayers (MOI = 2). These combinationsincluded ofloxacin/rifampicin, ofloxacin/tetracycline, and
ofloxacin/rifampicin/tetracycline.
Generation of recombinant chlamydial strains for analysis
of recombination hot spots
Multiple independent shell vials containing confluent
McCoy cells were inoculated sequentially with ofloxacin-
resistant D/UW3Cx and rifampin-resistant L1/440/LN
or L3/404/LN strains, and incubated 48 h in medium
lacking antibiotics. Monolayers were lysed and used as
inocula onto fresh McCoy cells at MOI = 1, and incu-
bated in the presence of 4X the MIC of the drugs used
for selection, rifampin and ofloxacin. These concentra-
tions were previously determined to be sufficient to se-
lect for individual recombinant strains resistant to both
drugs. Incubation of either parent in this combination and
concentration of antibiotics at MOI = 1 never yielded a
doubly resistant mutant parent. Chlamydial recombinants
growing in this mixture of antibiotics were propagated
and cloned by limiting dilution. Only a single recombinant
progeny was collected from each lineage from a single
original inoculated shell vial. DNA was harvested from
these clones, and PCR primers were created that flanked
regions of suspected recombination hotspots identified by
Srinivasan and colleagues [24]. The Phusion high fidelity
DNA polymerase (New England Biolabs, Ipswich, MA)
was used to generate PCR products from these regions,
and these were sequenced at the Oregon State University
Center for Genomics Research and Biocomputing. Se-
quences were then examined for possible recombination
by comparing informative sequence polymorphisms rela-
tive to each parent in the cross.
Chlamydia recombinant strain genomic DNA preparation
Recombinants were clonally isolated using limiting dilu-
tion and EB purification was conducted as previously de-
scribed [23,40]. Purified EBs were incubated for 60 min
with 4 units/mL RQ1 DNase (Promega) followed by treat-
ment with 2 mM EGTA (RQ1 Stop solution, Promega)
to inactivate the DNase. Elementary bodies were then
suspended in Qiagen Genomic buffer B1 supplemented
with dithiothreitol (5 mM) and DNA was then extracted
using the Qiagen Genomic Tip kit, (Qiagen, Valencia, CA)
following the manufacturer’s instructions.
Genome sequencing and sequence analysis
Genomic DNA from recombinant strains was processed
for Illumina-based paired-end sequencing using com-
mercial DNA preparation kits (Illumina Inc., San Diego,
CA) following the manufacturer’s instructions. Each
recombinant genome was first assembled using the
reference-guided assembly program Maq [41]. Appropri-
ate parental genomes were used as references in the ana-
lyses. Regions in reference-guided assembled genomes
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pared to contiguous sequences assembled using de-novo
assembly software Velvet [42] and a single contiguous
draft sequence was produced.
To confirm the clonality of the recombinant genomes,
and to quality control our assembly process, two to four
apparent crossover regions in each recombinant progeny
were amplified by PCR and sequenced using classical
Sanger sequencing. In all cases the sequenced amplicon
contained the appropriate informative sites from each
parent involved in the cross (not shown).
Recombinant maps of each genome were produced by
computationally parsing a draft genome against the two
parents used to generate the recombinant, using the
alignment program MAFFT with the default settings
[43,44]. Any detected crossover regions were manually
analyzed using MacVector sequence analysis software
(Cary, NC). Crossover regions were defined as the inter-
vening homologous sequence between two informative
sites (defined as a nucleotide position that varied in se-
quence between the two parent genomes), where the in-
formative site was the same as one parent at one position
and the same as the second parent at an immediately adja-
cent informative site.
Whole genome alignments including all recombinant
strains and the 3 parental strains were constructed using
MAFFT with default settings. Any position in this align-
ment where at least one genome had a variable base was
further analyzed using the Fisher exact test as a metric
to determine if the variable genotype could be associated
with a given phenotype. In these analyses, a low p-value
indicated an association between the base sequence and
a specific parental phenotype or genotype. A variable
genotype was considered to be associated with a given
phenotype if the calculated p-value was the lowest pos-
sible based on the sample size. The p-values calculated
by the Fisher’s exact test were inverse Log-transformed
and plotted using the statistical analysis program R
(http://www.r-project.org/).
Whole genome alignments of all recombinants against
both parents were used to determine if any random mu-
tations had occurred during culture and the generation
of recombinants. A random mutation was defined as a
nucleotide in the recombinant sequence that was diffe-
rent than the nucleotide of either parent at the same nu-
cleotide position. All ORF designations are based on
numbering system used for the C. trachomatis D/UW3
genome sequence [31].
Measurement of attachment efficiency
McCoy cell monolayers were seeded in duplicate 24 well
plates at 90% confluency, and triplicate wells of each
plate were infected using a target MOI = of 1. Plates
were then either centrifuged at 640 × g (2000 RPM onBeckman Coulter, Allegra X-15R centrifuge) for 1 h or
placed on a rocker platform for 1 h, with both treat-
ments being at room temperature. Wells were then
washed 3 times with Hanks balanced salt solution and
DNA was extracted directly from each well using the
Qiagen DNeasy Blood and Tissue kit, with the lysis buf-
fer supplemented with 5 mM dithiothreitol. Each sample
was pipetted up and down 10 times to disrupt both host
cells and chlamydiae. Genome copy number was deter-
mined for each treatment by qPCR, using a probe for
hsp60 (groEL_3, CT755). A cloned and quantified ver-
sion of CT755 was used as the standard curve on all
qPCR plates, ensuring that each sample being analyzed
was properly quantified. The target sequence for this
assay is conserved among C. trachomatis, but was
unique to this hsp60 allele, as demonstrated by PCR
analysis of alternate hsp60 open reading frames (CT110
and CT604; not shown). Attachment efficiency was then
calculated by dividing the genome copy number of the
rocked samples by the genome copy number of the
centrifuged samples.
Quantification of secondary inclusion formation
The frequency of secondary inclusion formation in par-
ental and progeny strains was determined using previ-
ously described methods [23]. Briefly, McCoy cells were
infected with the strain of interest at an MOI = of 0.3.
These cells were incubated for approximately 24 hpi
prior to fixation with methanol. C. trachomatis IncA was
labeled with mouse monoclonal anti-IncA, and chlamydial
developmental forms were labeled with mouse anti-
lipopolysaccharide [23]. Cells were then labeled with ap-
propriate secondary antibodies (Southern Biotechnology
Associates, Birmingham, AL) and observed using 400× or
1000× magnification. A semi-quantitative measure of
secondary inclusion formation was conducted by deter-
mining the fraction of infected cells having secondary
inclusions versus the total number of infected cells. A
1+ to 4+ scoring system was used to quantify secondary
inclusion formation and each score was determined on
three independent sets of coverslips. A 1+ value is
equivalent to less than 10% of infected cells having sec-
ondary inclusions, while a 4+ value is equivalent to 40%
or more of the cells having secondary inclusions.
Genome sequence accession numbers
The genome sequences of the parental strains used to
generate recombinant sequences and the previously se-
quenced C. trachomatis strains used in the whole genome
alignment studies are in the DDBJ/EMBL/GenBank data-
base under the following accession numbers: D/UW3Cx,
AE001273; L2-434Bu, AM884176; L2/UCH1, AM884177;
L1/440/LN, HE601950; L3/404/LN, HE601955; D(s)/2923,
ACFJ01000001; E/11023, CP001890; E/150, CP001886; G/
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88; F/70, ABYF01000001; F(s)/70, ABYG01000001; J/6276,
ABYD01000001; J(s)/6276, ABYE01000001.
The C. trachomatis genome accession numbers of the
recombinants used in this study have been deposited in
the DDBJ/EMBL/GenBank database under the following
accession numbers: RC-F/69, CP002671; RC-L2(s)/46,
CP002672; RC-F(s)/852, CP002673; RC-J/943, CP002674;
RC-J/953, CP002675; RC-L2(s)/3, CP002676; RC-F(s)/342,
CP002677; RC-J(s)/122, CP002678; RC-J/966, CP002679;
J/6276tet1, CP002680; RC-L2/971, CP002681; RC-L2/55,
CP002682.
Additional files
Additional file 1: Figure S1. Genome-wide association analysis of the
attachment efficiency phenotype. Genome-wide p-values from Fisher’s
exact test are given on the Y-axis. The results were collected from an
alignment of the twelve recombinants and the three parents used for
creating the recombinants. Genome position is indicated along X-axis,
beginning with CT001 as defined for the DUW/3 genome [31]. The
brackets and ORF numbers indicate the genes present in the genomic
regions showing the highest inverse p-values in these analyses.
Additional file 2: Table S1. Gene products associated with attachment
efficiency phenotype. D/UW3 and L2-434 gene designations, and
putative membrane localization are given for gene products with amino
acid changes that are associated with attachment efficiency. NS AA
changes indicate the number of non-synonymous amino acid changes
that are associated with attachment efficiency. Indel status indicates
whether an in-frame insertion or deletion within a protein is associated
with attachment efficiency. Elongation/truncation status indicated
whether a protein has either an N or C-terminal truncation/elongation
that is associated with attachment efficiency.
Additional file 3: Table S2. Polymorphic membrane protein charge
analysis. The numbers below each of the Pmp is the charge of the
protein at a pH of 7. The results of the three parental strains used in this
study as well as three previously sequenced non-LGV urogenital strains
are shown.
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